Examkin

Question

Difficulty: MediumGastroenterology and Hepatology

A 54-year-old man is evaluated in the hospital on day 4 of admission for a pyogenic liver abscess. He initially presented with a 3-day history of high fever, right-sided abdominal pain, and malaise. An abdominal computed tomography scan on admission revealed a 6-cm multiloculated fluid collection in the right hepatic lobe. He underwent prompt ultrasound-guided percutaneous catheter drainage, and empiric intravenous piperacillin-tazobactam was initiated.

Today, the patient reports significant improvement and is tolerating a regular diet. His temperature is 37.0°C (98.6°F), blood pressure is 122/78 mm Hg, and pulse is 76/min. The percutaneous drain output has decreased to less than 10 mL over the past 24 hours. Blood cultures drawn at admission are sterile. Cultures from the abscess fluid have grown *Klebsiella pneumoniae*. Antimicrobial susceptibility testing indicates the organism is resistant to ampicillin, but susceptible to amoxicillin-clavulanate, ceftriaxone, and ciprofloxacin.

Which of the following is the most appropriate next step in the antimicrobial management of this patient?

  1. Transition to oral amoxicillin-clavulanateAnswer
  2. B
    Continue intravenous piperacillin-tazobactam
  3. C
    Transition to oral ampicillin
  4. D
    Add intravenous fluconazole
  5. E
    Discontinue all antimicrobial therapy

Answer

The most appropriate next step is to transition the patient to oral amoxicillin-clavulanate.
This patient has a pyogenic liver abscess that has been appropriately managed with ultrasound-guided percutaneous drainage and empiric intravenous broad-spectrum antibiotics (piperacillin-tazobactam). He is now clinically stable, afebrile, and tolerating oral intake with minimal ongoing drain output. Abscess fluid cultures have grown *Klebsiella pneumoniae* that is susceptible to several oral agents, including amoxicillin-clavulanate. In patients with pyogenic liver abscesses who have achieved adequate source control and demonstrated clinical improvement, standard practice dictates transitioning from intravenous to targeted oral antibiotics to complete a total treatment course of 4 to 6 weeks. De-escalation to oral amoxicillin-clavulanate represents proper antimicrobial stewardship by utilizing a targeted, narrow-spectrum oral agent, thereby facilitating hospital discharge and minimizing the risks associated with prolonged intravenous access.

Step-by-Step Solution

1
Assess the patient's clinical status and response to initial therapy.
The patient is afebrile, hemodynamically stable, tolerating a regular diet, and drain output has appropriately decreased.
Clinical stability dictates whether a patient can be safely transitioned from intravenous to oral medications.
2
Review the antimicrobial susceptibility testing results from the abscess fluid cultures.
The organism, Klebsiella pneumoniae, is susceptible to amoxicillin-clavulanate, ceftriaxone, and ciprofloxacin, but resistant to ampicillin.
Culture and sensitivity data are required to select a targeted, narrow-spectrum antimicrobial agent.
3
Determine the appropriate duration and route of ongoing antimicrobial therapy.
The patient requires a total of 4 to 6 weeks of antibiotics, which can now be safely completed with targeted oral amoxicillin-clavulanate.
Once source control is achieved and the patient is clinically stable, de-escalating from broad-spectrum IV antibiotics to a targeted oral agent is the standard of care for pyogenic liver abscesses, avoiding the risks and costs of prolonged IV therapy.

Key Concept

Management of pyogenic liver abscess involves initial source control (percutaneous drainage) and empiric intravenous antibiotics, followed by de-escalation to targeted oral antibiotics once the patient demonstrates clinical improvement and culture results are available.
Estimated Time:1m 0s
Rate this question

Topics

Gastroenterology and Hepatology

More questions from this topic